The Food and Drug Administration (FDA) is inviting the public to comment on a proposed collection of information related to its Generic Drug User Fee Program. This proposal is part of fulfilling requirements under the Paperwork Reduction Act, which mandates a 60-day public comment period for proposed information collections. Comments can be submitted online through https://www.regulations.gov or via mail by March 17, 2025. The FDA seeks feedback on the necessity, accuracy, and methods of the information collection, and aims to support the implementation of its program through the information gathered.
Simple Explanation
The FDA wants to know what people think about how they collect money for making new medicine cheaper, and people have until March to tell them their thoughts. They want to make sure they are collecting only the important stuff and doing it the right way.